(3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

C22H38O3 — CID 163486005

IUPAC(3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESCO[C@H]1C[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1[C@H](C)O
InChIInChI=1S/C22H38O3/c1-13(23)20-19(25-4)12-18-16-6-5-14-11-15(24)7-9-21(14,2)17(16)8-10-22(18,20)3/h13-20,23-24H,5-12H2,1-4H3/t13-,14-,15-,16+,17-,18-,19-,20-,21-,22-/m0/s1
InChIKeyCIPKBTAUDISEKU-VZNRDTOWSA-N
MW350.54 g/mol
LogP4.01
Rot. Bonds2

About (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol (PubChem CID 163486005) has the molecular formula C22H38O3 and a molecular weight of 350.54 g/mol. Its IUPAC name is (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol.

Molecular Properties

Compound Name(3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
PubChem CID163486005
Molecular FormulaC22H38O3
Molecular Weight350.54 g/mol
Exact Mass350.28
IUPAC Name(3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESCO[C@H]1C[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1[C@H](C)O
InChIInChI=1S/C22H38O3/c1-13(23)20-19(25-4)12-18-16-6-5-14-11-15(24)7-9-21(14,2)17(16)8-10-22(18,20)3/h13-20,23-24H,5-12H2,1-4H3/t13-,14-,15-,16+,17-,18-,19-,20-,21-,22-/m0/s1
InChIKeyCIPKBTAUDISEKU-VZNRDTOWSA-N
XLogP4.01
TPSA49.69 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds2
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500350.54
LogP ≤ 54.01
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The IUPAC name of (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol (CID 163486005) is (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol.
What is the SMILES notation for (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The canonical SMILES for (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol is CO[C@H]1C[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1[C@H](C)O.
What is the InChIKey of (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The InChIKey is CIPKBTAUDISEKU-VZNRDTOWSA-N. The full InChI is InChI=1S/C22H38O3/c1-13(23)20-19(25-4)12-18-16-6-5-14-11-15(24)7-9-21(14,2)17(16)8-10-22(18,20)3/h13-20,23-24H,5-12H2,1-4H3/t13-,14-,15-,16+,17-,18-,19-,20-,21-,22-/m0/s1.
What are the key properties of (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol?
(3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol has a molecular weight of 350.54 g/mol, XLogP of 4.01, 2 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-[(1S)-1-hydroxyethyl]-16-methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol is sourced from PubChem (CID 163486005), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).